BSEBoard Meeting20 Aug 2026 · 20 Aug 2026, 06:34 pm

Board Meeting Outcome for the meeting held on August 20, 2026 For Declaration Of Unaudited Financial Results For The Quarter Ended June 30, 2026.

Manipal Health Enterprises Ltd · 544847

✦ AI SummaryResults

The Board of Directors of Manipal Health Enterprises Ltd has approved unaudited financial results for the quarter ended June 30, 2026, and other matters including the appointment of new statutory auditors, re-appointment of directors, and amendment to the Articles of Association.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Manipal Health Enterprises Ltd - 544847 - Board Meeting Outcome for Outcome Of The Board Meeting Held On August 20, 2026

Attachments (1)

📄

c817dc6b-658c-4cae-b58f-056b185297a2.pdf

pdf

Download →
View document text
Date: August 20, 2026 National Stock Exchange of India Limited, BSE Limited, Exchange Plaza, C-1, Block G, 20th Floor, P.J. Towers, Bandra Kurla Complex, Bandra (E), Dalal Street, Mumbai – 400 051 Mumbai - 400001. NSE Scrip Symbol: MANIPALHOS BSE Scrip Code: 544847 Subject: Outcome of the Board meeting of Manipal Health Enterprises Limited (“the Company”) Ref.: Disclosure under Reg. 33 and Reg. 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”) Dear Sir/Ma’am, We would like to inform you that the Board of Directors at its meeting held today i.e., August 20, 2026, which commenced at 6:00 P.M. (IST) and concluded at 6:15 PM (IST) have inter alia considered, and approved the following, subject to applicable provisions of the Companies Act, 2013 and Listing Regulations, including amendments, if any: 1. Unaudited financial results (both standalone and consolidated) of the Company for the quarter ended June 30, 2026, along with Limited Review Report with unmodified opinion issued by the Statutory Auditors of Company. Copies of the same are enclosed herewith; 2. Appointment of M/s Price Waterhouse Chartered Accountants LLP, Chartered Accountants (ICAI Firm Registration No. 012754N/N500016) as the Statutory Auditors of the Company to hold the office for a term of 5 (five) consecutive years from the conclusion of the 16th Annual General Meeting (“AGM”) of the Company to be held in the year 2026 till the conclusion of the 21st AGM to be held in the year 2031, subject to approval of the members of the Company and other statutory requirements; 3. Re-appointment of Dr. Hebri Sudarshan Ballal (DIN: 01195055), as Director, who is liable to retire by rotation, offers himself for re-appointment, at the 16th Annual General Meeting, subject to approval of members of the Company; 4. Re-appointment of Mr. Puneet Bhatia (DIN: 00143973), as Director, who is liable to retire by rotation, offers himself re-appointment, at the 16th Annual General Meeting, subject to approval of members of the Company; 5. Amendment to the Articles of Association (“AOA”) of the Company by inserting a new Article 99.10 relating to the right to nominate directors of the Company, along with the addition of the relevant definitions under Article 4 of the AOA, subject to the approval of the members of the Company. 6. Convening the 16th Annual General Meeting (“AGM”) of the Company on Tuesday, September 29, 2026 at 11:00 a.m. (IST) through Video Conferencing (VC) or Other Audio-Visual Means (OAVM). Further details pertaining to the AGM will be informed in due course of time. MHE-Public Further, the Board of Directors have inter alia considered, and noted the following, subject to applicable provisions of the Companies Act, 2013 and Listing Regulations, including amendments, if any: 7. Payment of the upside share amount by TPG SG Magazine Pte. Ltd. (“TPG”) to Manipal Research & Management Services International (“MRMSI”), one of the promoter group entities of the Company, in accordance with and subject to the terms of the upside sharing agreement dated March 16, 2026 executed between TPG and MRMSI (“Upside Sharing Agreement”). The Company is not a party to Upside Sharing Agreement. The implementation of the upside sharing arrangement, including settlement of the upside share amount, is subject to receipt of necessary approval from the shareholders of the Company, as required under Regulation 26(6) of the Listing Regulations The details pursuant to Regulation 30 read with Schedule III of the Listing Regulations and SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026, in respect of Items 2, 3 and 4 are set out in Annexure I, while the details in respect of Item 5 are set out in Annexure II. The above announcements will also be uploaded on the website of the Company and can be accessed using the link: https://www.manipalhospitals.com This intimation is being submitted for your information and records. Thank you. For Manipal Health Enterprises Limited (formerly known as Manipal Health Enterprises Private Limited) Sathish K R Company Secretary and Compliance Officer Membership No.: A15203 MHE-Public Annexure I Sr. Particulars Details No. M/s. Price Waterhouse Dr. Hebri Sudarshan Mr. Puneet Bhatia Chartered Accountants LLP Ballal 1. Reason for Change Appointment of M/s. Price Re-appointment of Dr. Re-appointment of Mr. viz. appointment, Waterhouse Chartered Accountants Hebri Sudarshan Ballal as Puneet Bhatia as the Resignation, removal, LLP (ICAI Firm Registration No. the Non-Executive Director Non-Executive Director death or otherwise. 012754N/N500016) as Statutory designated as Non- of the Company, who is Auditors of the Company for a Executive Chairman of the liable to retire by period of 5 years starting from the Company, who is liable to rotation, and offers conclusion of 16th AGM till the retire by rotation, and offers himself for re- conclusion of 21st AGM (i.e. from himself for re-appointment appointment subject to FY 2026-27 till 2030-31), subject to subject to the approval of the approval of the approval of the Members of the the shareholders, at the 16th shareholders, at the 16th Company and other statutory Annual General Meeting. Annual General requirements (including auditor Meeting. independence requirement for the Company), consequent to completion of tenure of M/s. BSR & Co. LLP, existing statutory auditors of the Company. 2. Date of Based on the recommendation of At the ensuing 16th Annual At the ensuing 16th appointment/cessation the Audit Committee, the Board General Meeting to be held Annual General (as applicable) & term approved and recommended the in FY 2026-27 and his term Meeting to be held in of appointment appointment of M/s Price is liable to retire by rotation. FY 2026-27 and his Waterhouse Chartered Accountants term is liable to retire by LLP (ICAI Firm Registration No. rotation. 012754N/N500016) as the Statutory Auditors of the Company for a term of 5 consecutive years, starting from the conclusion of the 16th AGM till the conclusion of the 21st AGM(i.e. from FY 2026-27 till 2030-31), subject to approval of the MHE-Public Members and other applicable statutory requirements. 3. Brief profile (in case Price Waterhouse & Co Chartered Dr. Hebri Sudarshan Ballal Mr. Puneet Bhatia is a of appointment) Accountants LLP, having a Firm is the Chairman and Non- Non-Executive Director Registration No. Executive Director of our of our Company since 012754N/N500016, is a firm of Company since October 29, February 26, 2015. He Chartered Accountants registered 2010. He holds a bachelor holds a bachelor’s with the Institute of Chartered of medicine, bachelor of degree in commerce Accountants of India. The firm was surgery (MBBS) degree and from Sriram College of established in the year 1991 and was a degree in doctor of Commerce, University converted into a limited liability medicine (MD) from the of Delhi and a post partnership in the year 2014. University of Mysore. He graduate diploma in has been certified by the management from the The registered office of the firm is American Board of Internal Indian Institute of at Plot No. 56 & 57, Block DN, Medicine in critical care Management, Calcutta. Sector V, Salt Lake, Kolkata - 700 medicine, nephrology and He is currently the 091 and more than 15 branch offices internal 298 managing director and in various cities in India as on date. medicine. He was also country head of TPG awarded an honorary Capital India Private The firm is primarily engaged in fellowship by the Royal Limited and has been providing assurance and auditing College of Physicians, associated with TPG services to its clients and is a London. He served as a Capital since 2002. member firm of Price Waterhouse fellow and professor of Prior to this, he was & Affiliates, a network of firms medicine with the St. Louis Chief Executive, Private registered with the Institute of University School o [Showing first 8,000 characters — download PDF for full document]